An Effective Therapeutic Approach for Oxaliplatin-Induced Peripheral Neuropathy Using a Combination Therapy With Goshajinkigan and Bushi

Cancer Biology and Therapy - United States
doi 10.1080/15384047.2016.1210742
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Factors Associated With the Development and Severity of Oxaliplatin-Induced Peripheral Neuropathy: A Systematic Review

Asia-Pacific Journal of Clinical Oncology
MedicineOncology
2017English

Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal Cancer

Journal of Pain and Symptom Management
NeurologyAnesthesiologyPain MedicineNursing
2017English

A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral Neuropathy

2019English

Longitudinal Assessment of Oxaliplatin-Induced Neuropathy

Neurology
Neurology
2011English

Prolonged Oxaliplatin Exposure Alters Intracellular Calcium Signaling: A New Mechanism to Explain Oxaliplatin-Associated Peripheral Neuropathy

Clinical Colorectal Cancer
OncologyGastroenterology
2011English

Measuring Therapy-Induced Peripheral Neuropathy: Preliminary Development and Validation of the Treatment-Induced Neuropathy Assessment Scale

Journal of Pain
NeurologyAnesthesiologyPain Medicine
2015English

Genetic Polymorphisms of SCN9A Are Associated With Oxaliplatin-Induced Neuropathy

BMC Cancer
Cancer ResearchOncologyGenetics
2017English

Chemotherapy-Induced Peripheral Neuropathy

JAMA Oncology
Cancer ResearchOncology
2019English

Hepatic Disorder Is a Risk Factor for Aggravation of Oxaliplatin-Induced Peripheral Neuropathy in Humans and Mice: Possible Involvement of HMGB1

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy